medigraphic.com
ISSN 1561-3038 (Print)

2016, Number 3

<< Back Next >>

Rev Cubana Med Gen Integr 2016; 32 (3)

Quality of life in menopause, a challenge in clinical practice

Lopera-Valle JS, Parada-Pérez AM, Martínez-Sánchez LM, Jaramillo-Jaramillo LI, Rojas-Jiménez S

Language: Spanish
References: 50
Page: 1-11
PDF size: 76.93 Kb.


ABSTRACT

Introduction: Menopause is an important stage in a women's life, therefore it requires a comprehensive study in daily clinical practice. Measuring the quality of life of menopausal women represents a challenge, that´s why the tools available in order to perform this comprehensive evaluation are indispensable in the medical evaluation; they allow us to correctly consider the patient´s point of view regarding their state of health. Objective: Explore the existing information in the literature about the quality of life in menopause to contextualize the reader in the most common topics related with alterations during this period in the life of women; finally a review of current data that focus on hormonal therapy as a possible treatment for a variety of symptoms that occur in this period. Methods: A search of the literature of original research articles in MEDLINE , EMBASE , Lilacs and ScienceDirect was conducted between July 2014 and March 2015, using combinations of keywords and MeSH terms related to menopause, , quality of life , comprehensive health care , women's health. For this review, we restricted the languages to Spanish and English. Conclusion: The instruments for assessing quality of life are an indispensable complement to the comprehensive clinical evaluation of these women, being that they correctly consider the patient's view of their state of health.


REFERENCES

  1. Gudmundsdottir SL, Flanders WD, Augestad LB. Physical activity and cardiovascular risk factors at menopause: The Nord-Trøndelag health study. Climacteric. 2013;16(4):438-46.

  2. Davis SR, Castelo-Branco C, Chedraui P, Lumsden MA, Nappi RE, Shah D, Villaseca P. Writing Group of the International Menopause Society for World Menopause Day 2012. Understanding weight gain at menopause. Climacteric. 2012;15(5):419-29.

  3. Gold EB, Crawford SL, Avis NE, Crandall CJ, Matthews KA, Waetjen LE, et al. Factors related to age at natural menopause: longitudinal analyses from SWAN. Am J Epidemiol. 2013;178(1):70-83.

  4. Pfister AK, Welch CA, Emmett MK, Sheets NW. Risk factors predicting fractures in early postmenopausal women. W V Med J. 2013;109(3):8-15.

  5. Urdaneta J, Cepeda M, Guerra M, Baabel N, Contreras A. Calidad de vida en mujeres menopausicas con y sin terapia de reemplazo hormonal. Rev. chil. obstet. ginecol. 2010;75(1):17-34.

  6. Mishra GD, Kuh D. Health symptoms during midlife in relation to menopausal transition: British prospective cohort study. BMJ. 2012;344:e402.

  7. Skjærvø GR, Røskaft E. Menopause: No support for an evolutionary explanation among historical Norwegians. Exp Gerontol. 2013;48(4):408-13.

  8. Coronado PJ, Sánchez-Borrego R, Ruiz MA, Baquedano L, Sánchez S, Argudo C, et al. Psychometric attributes of the Cervantes short-form questionnaire for measuring health-related quality of life in menopausal women. Maturitas. 2016 Feb;84:55-62.

  9. Jenabi E, Shobeiri F, Hazavehei SM, Roshanaei G. Assessment of Questionnaire Measuring Quality of Life in Menopausal Women: A Systematic Review. Oman Med J. 2015;30(3):151-6.

  10. Morris E, Currie H. Estrogen deficiency: Education for all! Menopause Int. 2013;19(2):55.

  11. Utian WH, Woods NF. Impact of hormone therapy on quality of life after menopause. Menopause. 2013;20(10):1098-105.

  12. Capote MI, Segredo AM, Gómez O. Climaterio y menopausia. Rev Cubana Med Gen Integr. 2011;27(4):543-57.

  13. Grisendi V, Spada E, Argento C, Plebani M, Milani S, Seracchioli R, et al. Agespecific reference values for serum FSH and estradiol levels throughout the reproductive period. GynecolEndocrinol. 2014;30(6):451-5.

  14. Takahashi TA, Johnson KM. Menopause. Med Clin North Am. 2015;99(3):521-34.

  15. Franco OH, Muka T, Colpani V, Kunutsor S, Chowdhury S, Chowdhury R, et al. Vasomotor symptoms in women and cardiovascular risk markers: Systematic review and meta-analysis. Maturitas. 2015;81(3):353-61.

  16. Portman DJ, Gass ML; Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. Menopause. 2014;21(10):1063-8.

  17. Urzúa A. Calidad de vida relacionada con la salud: Elementos conceptuales. Rev. méd. Chile. 2010;138(3):358-65.

  18. López A, González R. Actualización en menopausia: abordaje desde atención primaria. Rev Valenciana Med Fam. 2008;15:4-9.

  19. Lwow F, Jedrzejuk D, Dunajska K, Milewicz A, Szmigiero L. Cardiovascular disease risk factors associated with low level of physical activity in postmenopausal Polish women. GynecolEndocrinol. 2013;29(7):683-6.

  20. Lizcano F, Guzmán G. Estrogen Deficiency and the Origin of Obesity during Menopause. Biomed Res Int. 2014;2014:1-12.

  21. Nappi RE, Martini E, Martella S, Capuano F, Bosoni D, Giacomini S, et al. Maintaining sexuality in menopause. Post Reprod Health. 2014;20(1):22-9.

  22. Nappi RE, Palacios S. Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. Climacteric. 2014;17(1):3-9.

  23. Politano CA, Valadares AL, Pinto-Neto A, Costa-Paiva L. The metabolic síndrome and sexual function in climacteric women: a cross-sectional study. J Sex Med. 2015;12(2):455-62.

  24. Mohammadalizadeh S, Rezaei N, Hakimi S, Montazeri A, Taheri S, Taghinejad H, et al. Quality of life of postmenopausal women and their spouses: a community-based study. Iran Red Crescent Med J. 2015;17(3):e21599.

  25. Sharma S, Mahajan N. Menopausal symptoms and its effect on quality of life in urban versus rural women: A cross-sectional study. J Midlife Health. 2015;6(1):16- 20.

  26. Monterrosa Á, Blumel JE, Chedraui P. Calidad de vida de mujeres en postmenopausia. Valoración con "Menopause Rating Scale" de tres etnias colombianas diferentes. MedUNAB. 2009;12(2):80-5.

  27. Pinto D, Villagra HA, Moya JM, del Campo J, Pires R. Calidad de vida relacionada con la salud de adolescentes latinoamericanos. Rev Panam Salud Pública. 2014;35(1):46-52.

  28. Vinaccia Alpi S, Quiceno JM. Calidad de vida relacionada con la salud y enfermedad crónica: estudios colombianos. Psychologia.vAvances de la disciplina. 2012;6(1):123-36.

  29. Greene JG. A factor analytic study of climacteric symptoms. J Psychosom Res. 1976;20(5):425-30.

  30. Hunter M. The Women's Health Questionnaire (WHQ): The development, standardization and application of a measure of mid-aged women's emotional and physical health. Qual Life Res. 2000;9(1):733-8.

  31. Perz JM. Development of the menopause symptom list: a factor analytic study of menopause associated symptoms. Women Health. 1997;25(1):53-69.

  32. Utian WH, Janata JW, Kingsberg SA, Schluchter M, Hamilton JC. The Utian Quality of Life (UQOL) Scale: development and validation of an instrument to quantify quality of life through and beyond menopause. Menopause. 2002;9(6):402-10.

  33. Alder E. The Blatt-Kupperman menopausal index: a critique. Maturitas. 1998;29(1):19-24.

  34. Heinemann LA, Potthoff P, Schneider HP. International versions of the Menopause Rating Scale (MRS). Health Qual Life Outcomes. 2003;1:28.

  35. Hilditch JR, Lewis J, Peter A, van Maris B, Ross A, Franssen E, et al. A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas. 1996;24(3):161-75.

  36. Buendía J, Rodríguez R, Yubero N, Martínez V. Diseño y validación de un cuestionario en castellano para medir calidad de vida en mujeres posmenopáusicas: el cuestionario MENCAV. Atención primaria. 2001;27(2):58-66.

  37. Palacios S, Ferrer-Barriendos JJ, Parrila C, Castelo BrancoC, Manubens M, Alberich X, et al. Calidad de vida relacionada con la salud en la mujer española durante la perimenopausia y posmenopausia. Desarrollo y validación de la Escala Cervantes. Medicinaclínica. 2004;122:205-11.

  38. Hinrichsen G, Wernecke KD, Schalinski A, Borde T, David M. Menopausal symptoms in an intercultural context: a comparison between German women, Chinese women and migrant Chinese women using the Menopause Rating Scale (MRS II). Arch Gynecol Obstet. 2014;290(5):963-71.

  39. Tao M, Shao H, Li C, Teng Y. Correlation between the modified Kupperman Index and the Menopause Rating Scale in Chinese women. Patient Prefer Adherence. 2013;7:223-9.

  40. Dibonaventura MD, Chandran A, Hsu MA, Bushmakin A. Burden of vasomotor symptoms in France, Germany, Italy, Spain, and the United Kingdom. Int J Womens Health. 2013;5:261-9.

  41. Chedraui P, Pérez-López FR, Sánchez H, Sánchez P, Miranda O, Quispe P, et al. Application of the 10-item Cervantes Scale among mid-aged Ecuadorian women for the assessment of menopausal symptoms. Maturitas. 2014;79(1):100-5.

  42. Pérez-López FR, Fernández-Alonso AM, Pérez-Roncero G, Chedraui P, Monterrosa- Castro A, Llaneza P. Assessment of menopause-related symptoms in mid-aged women with the 10-item Cervantes Scale. Maturitas. 2013;76(2):151-4.

  43. Pérez-López FR, Cuadros JL, Fernández-Alonso AM, Chedraui P, Sánchez-Borrego R, Monterrosa-Castro A. Urinary incontinence, related factors and menopause-related quality of life in mid-aged women assessed with the Cervantes Scale. Maturitas. 2012;73(4):369-72.

  44. Kwak EK, Park HS, Kang NM. Menopause Knowledge, Attitude, Symptom and Management among Midlife Employed Women. J Menopausal Med. 2014;20(3):118- 25.

  45. Comhaire FH, Depypere HT. Hormones, herbal preparations and nutriceuticals fora better life after the menopause: part I. Climacteric. 2015;18(3):358-63.

  46. Comhaire FH, Depypere HT. Hormones, herbal preparations and nutriceuticals fora better life after the menopause: part II. Climacteric. 2015;18(3):364-71.

  47. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials. 1998;19(1):61-109.

  48. Hays J, Ockene J, Brunner R, Kotchen J, Manson J, Patterson R,et al.Effects of estrogen plus pro-gestin on health-related quality of life. N Engl J Med. 2003;348(19):1839-54.

  49. National Collaborating Centre for Women's and Children's Health. Clinical Guideline Methods, evidence and recommendations. London: Royal College of Obstetricians and Gynaecologists; 2015.

  50. Reid RL, Fortier MP. Menopausal hormone therapy and quality of life: too many pyjamas. J Obstet Gynaecol Can. 2014;36(11):953-6.




2020     |     www.medigraphic.com